Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $207.64B as of Saturday, July 25, 2026.
ENTERPRISE VALUE (EV)
$207.64B
CVS Health Corp.
Market Cap
$137.47B
Enterprise Value (EV)
$207.64B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CVS Health Corp. (CVS) | $137.47B | $207.64B |
| Pfizer Inc. (PFE)vs › | $139.86B | $202.62B |
| Danaher Corporation (DHR)vs › | $134.62B | $156.83B |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | $161.68B |
| Stryker Corporation (SYK)vs › | $126.60B | $138.96B |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.16B | $117.65B |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.53B | $116.77B |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | $175.09B |
| Medtronic plc (MDT)vs › | $106.51B | $132.52B |
| GSK plc (GSK)vs › | $103.60B | $130.81B |
Market Cap
$137.47B
Total Debt
$78.69B
Cash
$8.51B
Enterprise Value
$207.64B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
